Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists

被引:37
|
作者
Ji, Jianguo
Schrimpf, Michael R.
Sippy, Kevin B.
Bunnelle, William H.
Li, Tao
Anderson, David J.
Faltynek, Connie
Surowy, Carol S.
Dyhring, Tino
Ahring, Philip K.
Meyer, Michael D.
机构
[1] Nuerosci Res, Abbott Pk, IL 60064 USA
[2] NeuroSearch A S, Ballerup, Denmark
关键词
D O I
10.1021/jm070755h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel, potent neuronal nicotinic acetylcholine receptor (nAChR) ligands derived from 3,6-diazabicyclo[3.2.0]heptane have been synthesized and evaluated for binding affinity and agonist activity at the alpha 4 beta 2 nAChR subtype. Structure- activity relationship studies of these novel nAChR ligands focused on substitution effects on the pyridine ring, as well as stereo- and regiochemical influences of the 3,6-diazabicyclo[3.2.0]heptane core. Small 5-substituents on the pyridine ring had a modest impact on the binding affinities and functional activities. 6-Bromo, 6-chloro, and 6-methyl substituents on the pyridine ring led to increased binding affinities and improved functional activities. Most of the 6-N-pyridinyl -substituted 3,6-diazabicyclo[3.2.0]heptanes are selective for the alpha A beta 2 nAChR subtype. Compounds (IR,5S)-25, (I R,5S)55, and (I R,5S)-56 were virtually inactive as agonists at the h alpha 3 beta 4 nAChR but retained potency and efficacy at the h alpha 4 beta 2 nAChR subtype. 3-N-Pyridinyl-substituted series demonstrated more complex SAR. (IR,5R)39, (1R,5R)-41, and (IR,5R)-42 were found to be much more potent at the h alpha 3 beta 4.nAChR subtype, whereas (IR,5R)-38 and (JR,5R)-40 were very selective at the h alpha 4 beta 2 nAChR subtype. The SAR studies of these novel ligands led to the discovery of several compounds with interesting in vitro pharmacological profiles.
引用
收藏
页码:5493 / 5508
页数:16
相关论文
共 50 条
  • [41] Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists
    Sun, LQ
    Chen, J
    Bruce, M
    Deskus, JA
    Epperson, JR
    Takaki, K
    Johnson, G
    Iben, L
    Mahle, CD
    Ryan, E
    Xu, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (14) : 3799 - 3802
  • [42] Diazaspirocylic compounds as selective ligands for the α4β2 nicotinic acetylcholine receptor:: Aynthesis and pharmacological studies.
    Bhatti, BS
    Hawkins, GD
    Breining, SR
    Phillips, TY
    Mazuro, A
    Miller, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U908 - U909
  • [43] Design, synthesis, and characterization of picomolar selective a4b2 nicotinic acetylcholine receptor inhibitors
    Yenugonda, Venkata M.
    Xiao, Yingxian
    Levin, Edward D.
    Rezvani, Amir H.
    Tran, Thao T.
    Al-Muhtasib, Nour
    Wells, Corinne
    Slade, Susan
    Johnson, Joshua E.
    Kong, Hye-Sik
    Dakshanamurthy, Sivanesan
    Tomita, York
    Liu, Yong
    Paige, Mikell A.
    Kellar, Kenneth J.
    Brown, Milton L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [44] Structure-activity Relationship Study of Tachykinin Peptides for Development of Novel Neurokinin-3 Receptor Selective Agonists
    Misu, R.
    Oishi, S.
    Noguchi, T.
    Yamada, A.
    Ohno, H.
    Matsuda, F.
    Ohkura, S.
    Fujii, N.
    BIOPOLYMERS, 2013, 100 (03) : 256 - 256
  • [45] Structure-activity relationship study on senktide for development of novel potent neurokinin-3 receptor selective agonists
    Misu, Ryosuke
    Yamamoto, Koki
    Yamada, Ai
    Noguchi, Taro
    Ohno, Hiroaki
    Yamamura, Takashi
    Okamura, Hiroaki
    Matsuda, Fuko
    Ohkura, Satoshi
    Oishi, Shinya
    Fujii, Nobutaka
    MEDCHEMCOMM, 2015, 6 (03) : 469 - 476
  • [46] Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists
    Misu, Ryosuke
    Noguchi, Taro
    Ohno, Hiroaki
    Oishi, Shinya
    Fujii, Nobutaka
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (08) : 2413 - 2417
  • [47] Structure activity relationships of 7-azaindolines as selective M4 muscarinic acetylcholine receptor agonists
    Suwa, Atsushi
    Sumiyoshi, Takaaki
    Takai, Kentaro
    Konishi, Yasuko
    Uruno, Yoshiharu
    Ochi, Yoshiaki
    Enomoto, Takeshi
    Matsuda, Harumi
    Sakai, Mutsuko
    Nakako, Tomokazu
    Kiyoshi, Akihiko
    Uematsu, Yasuaki
    Kitamura, Atsushi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [48] Benzopyrans as selective estrogen receptor β agonists (SERBAs).: Part 2:: Structure-activity relationship studies on the benzopyran scaffold
    Richardson, Timothy I.
    Norman, Bryan H.
    Lugar, Charles W.
    Jones, Scott A.
    Wang, Yong
    Durbin, Jim D.
    Krishnan, Venkatesh
    Dodge, Jeffrey A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3570 - 3574
  • [49] Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor
    Richardson, TI
    Ornstein, PL
    Briner, K
    Fisher, MJ
    Backer, RT
    Biggers, CK
    Clay, MP
    Emmerson, PJ
    Hertel, LW
    Hsiung, HM
    Husain, S
    Kahl, SD
    Lee, JA
    Lindstrom, TD
    Martinelli, MJ
    Mayer, JP
    Mullaney, JT
    O'Brien, TP
    Pawlak, JM
    Revell, KD
    Shah, J
    Zgombick, JM
    Herr, RJ
    Melekhov, A
    Sampson, PB
    King, CHR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 744 - 755
  • [50] Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression
    Liu, Jianhua
    Yu, Li-Fang
    Eaton, J. Brek
    Caldarone, Barbara
    Cavino, Katie
    Ruiz, Christina
    Terry, Matthew
    Fedolak, Allison
    Wang, Daguang
    Ghavami, Afshin
    Lowe, David A.
    Brunner, Dani
    Lukas, Ronald J.
    Kozikowski, Alan P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7280 - 7288